Bayer Aflak Pharmaceutical Industries, as one of the largest pharmaceutical groups in the Middle East, is located in Azna, Lorestan Province, Iran. The company was established with the aim of developing the national pharmaceutical industry, supporting regional development, and improving public health, relying on up-to-date knowledge, advanced technologies, and skilled human resources.
This large complex consists of seven production plants as follows:
Veterinary Pharmaceutical Plant
Human Pharmaceutical Plant
Active Pharmaceutical Ingredient (API) Plant
Vaccine Production Plant
Serum Production Plant
Cosmetic and Personal Care Products Plant
Agricultural, Animal, and Household Pesticides Plant
All clean room facilities, production lines, and a significant portion of laboratory equipment have been supplied and installed from reputable European companies, including Zibler (Germany), Abtech (Germany), Easypharma (Italy), GF (Italy), Pharmore, and ICAS (Italy).
The Research and Development (R&D) unit of the company plays a key role in advancing technical knowledge and improving product quality. It collaborates with leading universities in Iran, including the University of Tehran, Karaj, Shahid Chamran University of Ahvaz, Shiraz University, Lorestan University, Shahrekord University, and Babol University, as well as prominent academic professors.
The company has obtained numerous national and international certifications and approvals, including GMP Iran and EU GMP, OHSAS certification from RoyalCert Germany, ISO 9001 and ISO 14001 from DAkkS Germany, ISO 17025 accreditation, the Science and Technology Park certificate, the Best Industrial Unit Award in 2017 (1396 SH), and the Top Entrepreneur Award in 2022 (1401 SH).
Bayer Aflak Pharmaceutical Industries, with the objective of supplying domestic pharmaceutical needs and expanding exports to regional markets, operates using cutting-edge global technologies while fully complying with GMP requirements, environmental standards, occupational safety, and quality regulations. The company is consistently committed to producing high-quality products in accordance with international standards.
With reliance on its skilled workforce, domestic expertise, and commitment to the national healthcare system, the company is dedicated to enhancing quality, achieving organizational excellence, and promoting sustainable development in the health sector, playing an effective role in the pharmaceutical industry at both national and regional levels.
